{"id":"W4415496365","doi":"10.1136/bmjno-2025-anzan.61","title":"3478 Baseline characteristics in the tolebrutinib phase 3 primary progressive multiple sclerosis perseus clinical trial","year":2025,"lang":"","type":"article","venue":"","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical trial; Multiple sclerosis; Baseline (sea); Phases of clinical research; Phase (matter)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011368,0.0004980479,0.001402907,0.0002790223,0.0002585255,0.000721615,0.0002702966,0.0006773827,0.00715247],"category_scores_gemma":[0.001688084,0.0001267042,0.001054396,0.0003912766,0.0001906088,0.0006875796,0.0001693207,0.001205472,0.001094879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005155565,"about_ca_system_score_gemma":0.0005548278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006569229,"about_ca_topic_score_gemma":0.001635656,"domain_scores_codex":[0.9995491,0.0001813571,0.00004538924,0.00008221116,0.00006276804,0.00007914672],"domain_scores_gemma":[0.9995856,0.0001661813,0.00009098291,0.00003057327,0.00004914024,0.00007755464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5540589,0.002184846,0.03480361,0.003785539,0.006784238,0.0004415186,0.00008893981,0.007081825,0.005328779,0.001554916,0.052372,0.3315148],"study_design_scores_gemma":[0.5998603,0.06858512,0.2335543,0.002252509,0.0109365,0.001273281,0.0001641567,0.01648314,0.002771363,0.008437197,0.05549486,0.0001872663],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8771067,0.07072876,0.00180574,0.004332318,0.0009647303,0.001184621,0.01393539,0.0003337505,0.02960799],"genre_scores_gemma":[0.9805665,0.004615649,0.0007142962,0.002267502,0.0003660452,0.001272776,0.006477536,0.000033599,0.003686223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00715247,"threshold_uncertainty_score":0.02392739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1026112787063947,"score_gpt":0.3941371644722241,"score_spread":0.2915258857658294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}